1 / 33

Anesthesia & ASD Occluder

Anesthesia & ASD Occluder. Presented By R3 顏郁軒 93/8/9. ASD Occluder. The first successful device closure of an ASD was performed in 1974 by King and Mills FDA granted approval two types of ASD occluder : Amplatzer septal occluder & CardioSEAL Septal Occluder. CardioSEAL Septal Occluder.

ull
Download Presentation

Anesthesia & ASD Occluder

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Anesthesia & ASD Occluder Presented By R3顏郁軒 93/8/9

  2. ASD Occluder • The first successful device closure of an ASD was performed in 1974 by King and Mills • FDA granted approval two types of ASD occluder : Amplatzer septal occluder & CardioSEAL Septal Occluder

  3. CardioSEAL Septal Occluder

  4. Amplatzer Septal Occluder

  5. Amplatzer Structure • The AMPLATZER Septal Occluder is a self-expandable, double disc device made from a nickel-titanium (Nitinol) wire mesh • Left atrial disk has a radius only 7 mm greater than the waist of the device (and thus the defect) and the right atrial disk is slightly smaller, being only 5 mm larger than the defect

  6. Patient Selection (1) • secundum ASD measuring less than or equal to 34 mm • Defect should be greater than 5 mm away from the coronary sinus, atrioventricular valves, and right upper pulmonary vein

  7. Patient Selection (2) Exclusion criteria include : • congenital heart disease that requires cardiac surgery • partial anomalous pulmonary venous return • Pulmonary vascular resistance greater than 7 Wood’s U • right-to-left shunting at the atrial level with a systemic saturation of less than 94% • recent myocardial infarction, unstable angina, • and decompensated congestive heart failure or significant right or left ventricular decompensation with an ejection fraction of less than 30%. • The initial lower weight limit was 8 kg

  8. Anesthetic Consideration • Ketamine for initial diagnosiswatch out patient’s hemodynamic status • General anesthesia later and monitored with NIBP , Oximeter , ETCO2 • TEE evaluation

  9. TEE Evaluation • the entire rim of the defect should be visualized • 要看的view : the mid-esophageal 4-chamber view at 0°, the short-axis view at 45° to 60°, and the biatrial long-axis view at 90° to 110°

  10. 五個Rim的看法 • ASD 的5個 portion • SPI : bicaval view • PSAI : four chamber view • AS : 和aortic root 的距離

  11. Sizing the defect (1) Two methods can be used • Pull technique • Static technique • The proper device size is selected as the stretched ASD size plus 1 mm

  12. Sizing the defect (2) • As reported in the literature , TEE may underestimate the size of the ASD, as determined by the stretched balloon diameter

  13. Sizing the defect (3) 原因 ： 1. ASD形狀不是圓的 2.ASD 的septum 可能不是在同一平面 3. ASD的形狀大小會隨著heart cycle而改 變4.ASD margin 的組織可能是軟或較硬的，所以用sizing balloon 來推向兩邊時會有一些差異

  14. Evaluation, procedure, and postprocedural assessment Preprocedure •   Define ASD location •   Define ASD size •   Define ASD number; look for fenestrations •   Delineate ASD rim •   Is it firm or pliable? •   Is it deficient at any point, eg, inferoposteriorly? •   Atrial septal aneurysm? •   Look for associated defects (MVP, APVD) •   Measure distance from ASD to MV, CS, RUPV

  15. Evaluation, procedure, and postprocedural assessment Intraprocedural •   Confirm guide wire in LA •   Confirm sizing balloon free in LA before inflation •   Confirm inflated balloon closes the defect •   Confirm delivery catheter in body of LA •   Ensure adequate deployment and positioning of LA disk •   Guide positioning during waist and RA disk deployment

  16. Evaluation, procedure, and postprocedural assessment • Watch for deployment difficulties •  Cobrahead malformation •  Chiari network entanglement •  Thrombus on catheters •  Assess adequacy of occlusion •  Review device relation to MV, CS, RUPV •  Check position stability during "Minnesota wiggle" •  Document degree of residual shunt through and around device

  17. Evaluation, procedure, and postprocedural assessment Postprocedural •   Check device position •   Check device structural integrity •   Assess residual shunt •   Monitor changes in right heart chambers •   Check relation to other structures (MV, RUPV) •   Look for potential complications: thrombus, infection

  18. Effectiveness of percutaneous device occlusion foratrial septal defect in adult patients withpulmonary hypertension • American Heart Journal November 2002 P877~880 • 29 adult patients • follow up of 21±14 months • Our findings suggest that percutaneous device occlusion of ASD in adult patients with pulmonary hypertension is safe and effective and provides significant and prolonged relief.

  19. Thanks For Your Attention !!!

More Related